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Abstract
U.S. healthcare consumers have access to various provider ratings from several
organizations that are meant to assist in selecting their healthcare providers. Leapfrog
Hospital Safety Grades is one such rating system that professes to allow consumers the
ability to select the best hospital for their care. However, since consumers ranking
mortality risk as their most important concern, it is essential to determine if Leapfrog
grades align with consumer expectations. Andersen’s Phase-4 behavioral model of
healthcare utilization was used as the foundation for understanding healthcare consumer
preferences. This study was designed to determine if Leapfrog grades are predictive of
CMS 30-day mortality rates for pneumonia, chronic heart failure, and acute myocardial
infarction data, while also adjusting for selected organizational descriptors: state of
residency, Medicare expansion, safety-net status, ownership type, teaching classification,
and number of licensed beds. Linear regression demonstrated that Leapfrog grades are
not reliable predictors of the 3 inpatient mortality rates analyzed. The study demonstrated
that ownership type was a significant predictor for 2 of the 3 dependent variables.
Furthermore, most of the covariates also provided some predictive value for at least 1 of
the included outcomes; however, in most cases, the effect (β) was small. This study can
help provide positive social change by elucidating that Leapfrog grades are not reliable
predictors of patient outcomes for consumers, while also demonstrating that efforts to
reduce 30-day mortality rates, especially for pneumonia, can be targeted by selected
states, ownership type, and teaching status.
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Section 1: Foundation of the Study and Literature Review
Introduction
Consumer available provider comparative quality information has been increasing
in availability since the passage of the Affordable Care Act (Scanlon, Shi, Bhandari, &
Christianson, 2015). Such quality comparative data is currently available from many
sources, ranging from private to public entities that may or may not charge for
participating. My goal with this study was to determine if the publicly available hospital
Leapfrog Hospital Safety Grades (Leapfrog grades) provide consumers with information
that is predictive of Centers for Medicare and Medicaid Services (CMS) 30-day mortality
rates for three diagnoses (pneumonia, congestive heart failure [CHF], and acute
myocardial infarctions [AMI]).
Problem Statement
U.S. healthcare is so complex that the seemingly simple act of comparing health
outcome data, hospital safety information, and organization descriptors among healthcare
enterprises has proven difficult. Several rating organizations, using their proprietary
rating systems, have attempted to compare hospitals. The problem with these rating
systems is that they measure different operational aspects and do not correlate with each
other (Rothberg, Morsi, Benjamin, Pekow, & Lindenauer, 2008). The lack of correlation
only adds to the confusion that healthcare consumers are already experiencing when
selecting a hospital in which to receive their care. Austin et al. (2015) demonstrated how
not a single hospital is designated as a high performer among all four rating systems (The
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Leapfrog Group, U.S News, Hospital Compare, and Consumer Reports) they analyzed.
The authors stated that only 10% of the hospitals that appeared in any single rating
system as a high performer was rated as a high performer by any other rater (Austin et al.,
2015). With so much disparity among the various survey findings, one begins to question
if the rating systems are valid as a resource to consumers for selecting their healthcare
providers.
Consumer-oriented scores/grades from each rating organization’s unique
evidence-based quality indicator framework are meant to guide healthcare consumers in
selecting their healthcare providers based on a proprietary score/grade of excellence
(Austin et al., 2015). Hence, this research addressed the gap that exists in determining if
the Leapfrog consumer rating system is a good predictor of patient outcomes.
Purpose of the Study
The primary purpose of this study was to determine if Leapfrog hospital grades
are predictive of patient mortality rates for pneumonia, AMI, and CHF using CMS
datasets from all hospitals that have sufficient data elements from eight states (GA, MD,
OH, NC, PA, TN, VA, and WV), similar to other Leapfrog-focused studies (Pakyz,
Wang, Ozcan, Edmond, & Vogus, 2017). While other studies have looked at the
relationship between an organization’s financial performance and CHF, AMI, and
pneumonia mortality rates (Nguyen, Halm, & Makam, 2016), this study was unique in
that it looked at the information available to consumers on which they base their
healthcare purchasing decisions. Secondarily, a comparison of the linear regressions
derived from each organization’s grade was used to determine if the hospital grade was
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predictive of the 30-day mortality data. Since the most significant measure of a healthcare
organization’s quality is patient outcomes (e.g., mortality rates), by performing a
retrospective analysis one can compare if the rating organization’s provided healthcare
grades are correlated with hospitals that have better patient outcomes. Additional
stratifications using covariates of hospital-level quality data and descriptors (e.g.,
ownership type) were used to look for relationships, using regression analysis, and biases
that existed between the grades and other independent variables.
Research Questions and Hypotheses
RQ1: Does an organization’s Leapfrog grade demonstrate a statistically
significant correlation with the CMS pneumonia mortality rate data adjusting for each
covariate: licensed beds, ownership type, state of residency, safety net hospital status,
state Medicaid expansion status, and organization’s teaching status?
H11: The available consumer available health organization’s Leapfrog grade is
predictive of patient pneumonia mortality rate data adjusting for each covariate: licensed
beds, ownership type, state of residency, safety net hospital status, state Medicaid
expansion status, and organization’s teaching status.
H01: There is no correlation between Leapfrog grades and patient health mortality
rates based on pneumonia data adjusting for each covariate: licensed beds, ownership
type, state of residency, safety net hospital status, state Medicaid expansion status, and
organization’s teaching status.
RQ2: Does an organization’s Leapfrog grade demonstrate a statistically
significant correlation with CMS congestive heart failure (CHF) patient mortality rate
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data adjusting for each covariate: licensed beds, ownership type, state of residency, safety
net hospital status, state Medicaid expansion status, and organization’s teaching status?
H12: The available consumer available health organization’s Leapfrog grade is
predictive of patient chronic heart failure (CHF) mortality rate data adjusting for each
covariate: licensed beds, ownership type, state of residency, safety net hospital status,
state Medicaid expansion status, and organization’s teaching status.
H02: There is no correlation between Leapfrog grades and patient mortality rates
based on CHF data adjusting for each covariate: licensed beds, ownership type, state of
residency, safety net hospital status, state Medicaid expansion status, and organization’s
teaching status.
RQ3: Does an organization’s Leapfrog grade demonstrate a statistically
significant correlation with CMS acute myocardial infarctions (AMI) patient mortality
rate data adjusting for each covariate: licensed beds, ownership type, state of residency,
safety net hospital status, state Medicaid expansion status, and organization’s teaching
status?
H13: The available consumer available health organization’s Leapfrog grade is
predictive of patient pneumonia mortality rate data adjusting for each covariate: licensed
beds, ownership type, state of residency, safety net hospital status, state Medicaid
expansion status, and organization’s teaching status.
H03: There is no correlation between Leapfrog grades and patient health mortality
rates based on pneumonia data adjusting for each covariate: licensed beds, ownership

5
type, state of residency, safety net hospital status, state Medicaid expansion status, and
organization’s teaching status.
Theoretical Foundation of the Study
I used Andersen’s behavioral model of healthcare utilization (Andersen, 1995).
This approach was appropriate for ascertaining if the quantitative data were predictive for
determining if an association existed between the independent variables (grades and
descriptive characteristics) and the dependent variables (30-day mortality rates).
Specifically, the three dependent variables used for this study consisted of pneumonia,
CHF, and AMI 30-day mortality rates derived from publicly available CMS data.
Andersen described in his Phase-4 model that consumers’ preference and satisfaction
play an essential part in the selection of healthcare services (Andersen, 1995). This
comparison included both the independent and dependent variables that are publicly
available to healthcare consumers and are meant to influence patient preference and
provider selection.
Nature of the Study
The study was a quantitative study using a secondary dataset obtained from the
Centers for Medicare and Medicaid Services (CMS), The Leapfrog Group, and the
American Hospital Association (AHA). The study was conducted to determine if the
Leapfrog’s publicly available organization health grades are reliable predictors of 30-day
mortality rates (pneumonia, CHF, AMI) that are derived from the CMS database. Further
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analysis was performed assessing whether the outcome data demonstrated bias by also
correlating with the descriptor elements (covariates) with the same health outcome data.
The study was built upon similar studies that also looked to correlate the
predictability of publicly available health scores/grades and quality indicators. One
similar study looked to determine a relationship between Leapfrog scores and hospitalacquired infections (Pakyz et al., 2017) and provides an approach that was used for this
research study.
Literature Search Strategies
The Walden University and the Virginia Commonwealth University (VCU)
online libraries and Google Scholar were searched using various keywords and phrases
(e.g., consumer healthcare data, Leapfrog, HQA, patient mortality rates, Anderson’s
behavioral model, and Hospital Compare). The various searches were refined to
primarily display articles that were published within the immediate past 5 years (2014 –
2018). Articles primarily from ProQuest Central, MEDLINE, PubMed, SAGE Journals,
CINAHL Plus, and from peer-reviewed sources were used.
Additional sources of relevant articles were found within the various journal
articles being reviewed. This process led to chaining of related papers that was initiated
by the original keyword search approach but allowed for the finding specific articles of
interest in either the Walden University or Virginia Commonwealth University databases.
This approach was found to be an excellent source of additional articles; however, this
approach often led to articles that were outside of the 5-year primary search period.
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The main subjects of the literature searches pertained to the main sections and
themes of this paper. The significance of each article used in this paper is described
within the areas they are referenced.
Literature Review
Introduction
The U.S. healthcare system has been on a journey towards improving the quality
of patient care based on current best practices, expanding access, and decreasing costs.
The healthcare industry has relied upon the use of quality benchmarking for measuring
improvements to differentiate organizational quality. However, to date, the improvement
of healthcare quality initiatives has produced limited improvement using current quality
indicators (Burstin, Leatherman, & Goldmann, 2016). As quality benchmarking
continues to help determine organizational reimbursement through quality reimbursement
modeling, it has been demonstrated that this approach may lead to organizations
becoming less likely to improve the organization’s quality of care measures due to the
loss of revenue (Manary, Staelin, Boulding, & Glickman, 2015). Quality improvement is
becoming more critical as healthcare reimbursement is partially determined using quality
measures, including patient survey data.
The fact that quality outcome data surveys are now part of the reimbursement
level calculations, some hospitals may be negatively impacted by the nature of the data
collected and presented to the public as hospital quality indicators. Figueroa, Wang, and
Jha (2016) demonstrated that reimbursement penalties adversely impact the problems
associated with comparing hospitals using the pay-for-performance (P4P) models. These
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issues associated with these reimbursement models have also demonstrated that large,
major teaching, and safety-net hospitals are notably more negatively impacted more than
other hospital types (Figueroa et al., 2016; Manary et al., 2015). This data would imply
that major academic medical centers, which tend to be large major teaching safety-net
hospitals, would be the most impacted of all hospital types. However, large, major
teaching, and safety-net hospitals are not the only organizational characteristics that are
predictive of profitability, and as discussed above, impact quality indicators.
Patient acuity, based on case mix index, demonstrates a statistical difference
among organizations with diverse ownership types, university affiliations, teaching
status, and as expected, trauma center level designations (Mendez, Harrington,
Christenson, & Spellberg, 2014). Furthermore, using both private and government payer
data, some patterns begin to emerge that can predict profitability among system types and
locations (Bai & Anderson, 2016) that could be based on acuity differences.
The use of the 30-day mortality rate has been used to provide consumers with a
quality indicator needed to help determine hospital quality (Shahian, Wolf, Iezzoni, Kirle,
& Normand, 2010). Hu et al., (2017) determined that Hospital Compare’s overall scores,
which are derived from the various quality indicators, did not demonstrate a correlation
that would allow for consumers to make informed healthcare decisions. However, the
authors did not specifically attempt to correlate 30-day mortality rates for pneumonia,
CHF, and AMI with the Hospital Compare scores, or any of the other available
scores/grades (e.g., Leapfrog), and instead analyzed at all the quality indicators to
determine consistency among the scores and all quality indicators used in calculating
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each organization’s score (Hu et al., 2017). Therefore, with the advent of multiple
publicly available scores/grades, the question then becomes which, if any, of the quality
indicators, correlate with the scores/grades that assigned to each hospital.
Leapfrog Group Organization Grades
Organizational Overview
The Leapfrog Group produces letter safety grades for acute care hospitals (A, B,
C, D, or F) to provide consumers with information to select safe hospitals from which to
receive their care. Leapfrog describes themselves as
The Leapfrog Group is a nonprofit watchdog organization that
serves as a voice for health care purchasers, using their collective
influence to foster positive change in U.S. health care. Leapfrog is
the nation’s premier advocate of hospital transparency—collecting,
analyzing and disseminating hospital data to inform value-based
purchasing. (The Leapfrog Group, n.d.)
The Leapfrog grades are made available to the public on the organization’s
website. Consumers can search for various hospitals and compare safety grades to guide
provider selection.
Scoring Methodology
For the Fall 2018 grades, Leapfrog’s grade for each organization is determined
through the weighting of 28 national performance measures derived from CMS data,
Leapfrog’s organization survey, and other secondary data sources such as the American
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Hospital Association’s Annual Survey and IT Supplement (The Leapfrog Group, 2018,
p.4). The grade is calculated by converting the various performance measures into a zscore and then, using Leapfrog’s proprietary weighting, used to produce value, that if
higher than the mean, is considered better performance, and lower than the mean, is
considered worse. (Austin et al., 2014).
Usefulness of Consumer Available Health Scores/Grades
As healthcare moves towards a consumer-driven marketplace, hospital
reimbursement levels will be impacted by consumers. The Hospital Value-Based
Purchasing Program implemented by CMS calculates hospital reimbursement levels on
patient outcomes, consumer satisfaction, quality indicators, and efficiency scores
(Manary et al., & Glickman, 2015). Currently, CMS satisfaction scores account for 1.5%
of hospital reimbursement (Tefera, Lehrman, & Conway, 2016). It can be expected that
reimbursement will continue to be increasingly dependent on hospital performance and
patient satisfaction.
The various formulations by Leapfrog, Hospital Compare, and Consumer Reports,
and others consider, through a proprietary combination of hospital performance, safety,
and patient satisfaction, to produce a score/grade that helps consumers determine where
to receive their care (Austin et al., 2015). Therefore, the availability of consumer
scores/grades has the potential to influence which hospitals consumers select to receive
their care (Sandmeyer, & Fraser, 2016). However, the authors stipulated that consumers
as a whole have yet to begin to use these available scores/grades to make their healthcare
decisions (Sandmeyer, & Fraser, 2016). Regardless, it is important to determine if the
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scores/grades are providing consumers with information that correlates with performance
(e.g., 30-day mortality rates) and not merely stylistic (e.g., hotel-like lobbies) approaches
that pander to consumerism.
For example, The Malcolm Baldrige National Quality Award uses quality,
leadership, business, and satisfaction data indicators to select the award winners (Evans
& Mai, 2014). While the Baldrige Award is a coveted and respected award, hospitals that
win the award have not demonstrated a difference from other organizations when
comparing CMS patient outcomes or satisfaction scores (Schulingkamp & Latham,
2015).
Hospitals are in the business to treat and care for the sick and injured.
Organizations continue to pursue higher patient satisfaction scores to improve both their
patient care, reimbursement levels, and to have higher ratings than their competitors for
marketing purposes (Smith, Reichert, Ameling, & Meddings, 2017). The question must
be asked if Leapfrog grades reliably predict 30-day mortality rates for pneumonia, AMI,
and CHF. With the new emphasis on aesthetics and concierge services, it cannot be
forgotten that patients’ outcomes are at the core of hospitals existence; and reduced
mortality rates remain patients’ primary concern (Mühlbacher & Bethge, 2015).
30-day Mortality Rates (Dependent Variables)
The usefulness of using the CMS derived data must be demonstrated to perform
an analysis using available Leapfrog grades for predicting hospital-level patient 30-day
mortality rates. First, it had to be determined if dependent variables are useful in
demonstrating correlations among hospitals. Dy et al. (2016) were able to demonstrate
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that 30-day mortality rates for CHF among 895 U.S. hospitals were correlated with
patient satisfaction scores (HCAHPS) and readmission rates. However, the authors found
that heart failure mitigation quality process indicators (e.g., ACE inhibitors) did not
demonstrate any statistical correlation (Dy et al., 2016). The same correlations between
readmission rates and all three 30-day mortality rates have also been demonstrated (Hu et
al., 2017). Other studies using CHF, AMI, and pneumonia 30-day mortality data and
were able to demonstrate that the only CHF mortality rates, and not AMI and pneumonia
rates, were correlated with quality measure data (Ryan, Nallamothu, & Dimick, 2012).
Therefore, the usefulness of the three selected dependent variables, and the fact they are
independent of each other, has been demonstrated.
The rates for the 30-day mortality rates are recorded as a percentage of deaths <
30 days from the date of admission. The CMS 30-day mortality rates are risk adjusted
for age, medical history, and comorbidities (CMS.gov, 2016).
Independent Variables
Leapfrog
Leapfrog Group developed a hospital safety grade (A, B, C, D, or F) based on
both survey results and other publicly available data. The hospital score is made
available to the public on the organization’s website to provide consumers with the
ability to compare hospitals across the United States. The unique aspect of the Leapfrog
grade is the focus on patient safety and not direct patient outcomes (e.g., 30-day mortality
rates) or satisfaction survey data (e.g., HCAHPS). Again, making the argument that
patient outcomes (i.e., the prevention of patient death) are the ultimate goal for hospitals,
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then one must ask if the Leapfrog grades, based on patient safety indicators, correlate
with outcome data.
Austin et al. (2014), did determine that Leapfrog grades demonstrate statistically
significant negative bias based on region, number of beds, and ownership type.
However, one of the significant issues with the Leapfrog grade is that participants who
complete the proprietary survey get to use their data. For organizations that do not wish
to pay and complete the Leapfrog survey, the Leapfrog Group uses a combination of
publicly available safety data and a process of exclusion and recalibration of the data
(Austin et al., 2014). This self-reporting of results allows for organizations to produce
values based on their own criteria and not necessarily the same as the CMS reporting
methodology. This inconstancy has demonstrated that self-reporting produced better
values than those reported to CMS (Smith et al., 2017). Furthermore, this could
potentially cause those hospitals that self-report to have more favorable grades than those
hospitals that do not self-report. Smith et al. (2017) did demonstrate that self-reporting of
results did produce improved scores over those organizations that did not self-report and
whose CMS data was used. Additionally, the authors also found that the self-reported
values had little association with the mandatorily reported CMS data (Smith et al., 2017).
Covariates and 30-day Mortality Rates
Safety-net status. Safety-net hospitals do not have a single definition. For this
study, the definition used by Gilman et al., (2015) will be used. Gilman et al. defined
safety-net hospitals as those organizations that are in the top quartile for receiving the
highest percentage of disproportionate-share hospital (DSH) payments for providing
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uncompensated care. In this study, I analyzed each state separately, and the top quartile
of hospitals in each state was designated as safety-net facilities to divide the hospitals for
this covariate analysis.
The purpose of including safety-net status as a covariate is due to differences in
hospital profitability. Hospitals that provide increased amounts of uninsured patient care
are less profitable (Bai & Anderson, 2016). It is easy to understand that if an
organization is less profitable, there could potentially be decreased investments in capital
and infrastructure that might directly or indirectly impact patient outcome data. Contrary
to what might be expected, safety-net hospitals, organizations that have increased
Medicaid patients and an increasingly disproportionate amount of uncompensated care
(Gilman et al., 2014), have been shown to have no statistical difference between patient
outcomes when compared to nonsafety-net hospitals (Gilman et al., 2015). Therefore, it
would be expected that an organization’s safety-net designation should not influence the
designated Leapfrog grade. While the various analyses performed used direct
correlations between safety-net designation and 30-day mortality rates, I used safety-net
status as a covariate to see if the scores/grades demonstrate any statistically significant
correlations.
Ownership type. Ownership type has been used to differentiate hospital
performance to determine if the philosophical and mission differences make a difference
in patient outcomes (Zhao, Haley, Spaulding, & Balogh, 2015). Ownership type for this
study was divided into three groups: for-profit, not-for-profit, and public. When AMI,
CHF, and pneumonia hospital readmissions were previously analyzed using hospital
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ownership as a variable, it was determined to have limited effect on the variability
demonstrated among hospitals (Herrin et al., 2015). However, the authors looked at
readmission rates and not mortality rates for the same three outcomes. Furthermore,
Herrin et al., (2015) also used geographic location as the primary variable which
accounted for 58% of hospital variability for the above readmission rates. Therefore, the
slight increase in hospital variability that may have been attributable to hospital
ownership could still be significant, just less than location.
When other studies, at least in Chile, there were differences demonstrated among
hospitals with different ownership types for total mortality rates (Cid Pedraza, Herrera,
Prieto Toledo, & Oyarzún, 2015). While the Chilean authors looked at total mortality
rates, this study will include a more focused 30-day mortality rate for only three patient
outcomes (i.e., CHF, AMI, and pneumonia) using CMS data for the included eight states.
Teaching status. An organization’s teaching status has been shown to
demonstrate outcome differences regarding patient outcomes. Burke, Frakt, Khullar,
Orav, and Jha (2017) were able to demonstrate that teaching hospitals did demonstrate
statistically lower mortality rates for CHF, AMI, and pneumonia outcomes when
compared to nonteaching hospitals. Furthermore, the authors were also able to
demonstrate a gradient for these three outcomes among hospitals that were defined as
major teaching, minor teaching, and nonteaching (Burke et al., 2017). The gradient
demonstrated increased mortality rates as the status went from major to minor to
nonteaching hospitals (Burke et al., 2017). However, other studies demonstrated no
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differences for other mortality rates (open versus endovascular aortic aneurysm repairs)
between teaching and nonteaching hospitals (Hicks et al., 2016).
This study used the teaching status, using the AHA annual survey hospital
responses to identify hospitals teaching status. While this study compared teaching status
and the 30-day outcomes for CHF, AMI, and pneumonia, the status served as a covariate
helping to demonstrate if the indirect variables demonstrate variability among hospitals
of the various teaching statuses.
AHA survey data delineated among the three teaching statuses: major being
members of both the Accreditation Council for Graduate Medical Education (ACGME)
and Association of American Medical Colleges (AAMC) Council of Teaching Hospitals
(COTH); minor is defined as those accredited by ACGME, but are not COTH members;
nonteaching are all hospitals without either ACGME or COTH membership (Rivard,
Christiansen, Zhao, Elixhauser, & Rosen, 2008).
Licensed beds (size). Hospital size is customarily defined by the number of
licensed beds that the facility has available to provide patient care. The correlation is
often believed that larger size facilities offer more diverse and sophisticated care. The
use of hospital size as a covariate is not meant to determine why any difference that may
be demonstrated for 30-day mortality rates among facilities. Nor is the study meant to
speculate and why these differences, if any, exist; but rather to demonstrate if hospital
size is correlated, positively or negatively, when compared to the hospital Leapfrog
grades. While bed size is not to indicate a direct causal factor and purely a predictor
variable, differences among hospitals based on size have been demonstrated. Sheetz,
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Dimick, and Ghaferi (2016) were able to demonstrate that hospital size was a predictor of
patient outcomes (e.g., failure to rescue) with smaller hospitals (< 200 beds) performing
statistically worse than larger hospitals (> 200 beds). For this study, beds were separated
into four groups (< 100 beds, 100 – 199 beds, 200 – 499 beds, and >500 beds) to
determine if differences were demonstrated among the various hospital size groupings.
State of residency. Because of differences in state health policies, the study will
also look to determine if the state in which the hospital is located provides any
statistically significant bias regarding Leapfrog grades. To help mitigate geographic
differences among patients from each state, the states used for this study are also
relatively clustered together with each state sharing a border with at least two other states,
and with six of the eight sharing a border with at least three study states (Figure 1).
Health disparities among various states and U.S. geographic regions have been
noted, including mortality rates. Roth et al., (2017) was able to describe significant
differences among various U.S. geographical regions when comparing mortality rates for
heart disease and stroke. Because some of these differences have been attributed to
socioeconomic differences (Singh, Siahpush, Azuine, & Williams, 2015), it only adds to
the necessity to reduce geographic variability by keeping the study states in the same
general region (see Figure 1).
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Figure 1: States used for the study
Medicaid expanded versus nonexpanded states. There have been mixed results
from studies regarding health disparities between states that expanded Medicaid and
those that did not expand Medicaid under the Affordable Care Act (ACA; Bhatt & BeckSagué, 2018; Anderson et al., 2016). In states that expanded Medicaid, infant mortality
was found to be lower (Bhatt & Beck-Sagué, 2018). However, other studies have not
shown any difference when comparing states that did and did not expand Medicaid for in
length of stay and other mortality rates (Anderson et al., 2016).
The inclusion of Medicaid expansion is not meant to determine if there is a direct
causal effect with Leapfrog grades, but rather to see if hospitals in states with Medicaid
expansion are statistically significantly different from those that did not expand
Medicaid. Table 1 lists the states included (four that expanded and four did not expand
Medicaid) and their Medicaid status as of December 31, 2018 (Kaiser Family
Foundation, 2018).
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Table 1
Study Inclusion States and their Medicaid Expansion Status
State
Maryland
Ohio
Pennsylvania
West Virginia
Georgia
North Carolina
Tennessee
Virginia

Medicaid Expansion
(as of 12/31/2018)
Yes
Yes
Yes
Yes
No
No
No
No

Comments

Medicaid Expanded on
January 1, 2019

Definitions
30-day Mortality rate: The rate of death within 30 days of entering the hospital
with a given condition (Medicare.gov, n.d.).
Acute Myocardial Infarction (AMI): A sudden onset heart attack “when there is
evidence of myocardial necrosis in a clinical setting consistent with acute myocardial
ischemia” (Thygesen et al., 2012, p. 1584).
Affordable Care Act (ACA): The U.S. healthcare law enacted in March of 2010
(HealthCare.gov, n.d.).
Center for Medicare and Medicaid Services (CMS): The federal agency
designated to administer the U.S. Medicare program and assist states with the Medicaid
program (CMS.gov, 2006).
Chronic Heart Failure (CHF): A condition that is present when a patient exhibits
symptoms of heart failure over a period of time (Ponikowski et al., 2016).
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Hospital Compare: Hospital Compare “is a consumer-oriented website that
provides information on how well hospitals provide recommended care to their patients”
(CMS.gov, 2016, p. 1).
Leapfrog Group (Leapfrog): A nonprofit organization that provides hospital data
for the purpose of informing the public to help facilitate value-based purchasing using
hospital grades (The Leapfrog Group, n.d.)
Licensed beds (size): The number of patient beds that a hospital is allowed to
operate (Agency for Healthcare Research and Quality, 2005). The larger the number of
beds is a good approximation of relative hospital size.
Medicaid: A healthcare program to help with medical costs for individuals with
low and limited income that is comanaged by states and the federal (CMS.gov, 2006).
Medicaid expansion: A designation for states that have selected to provide
Medicaid coverage to citizens that are within 138% of the federal poverty level as
allowed by the ACA (Kaiser Family Foundation, 2018).
Ownership type: A designation that indicates if a hospital is a for-profit, not-forprofit, government (nonfederal), or federal organization (Zhao, Haley, Spaulding, &
Balogh, 2015). Federally managed hospitals are excluded from this study.
Pneumonia: An infection of the lungs that causes the lung sacs, alveoli, to fill
with fluid and inhibit the normal gas exchange process leading to difficulty in breathing
(Prina, Ranzani, & Torres, 2015).
Safety-net hospital: A designation for hospitals that provide a disproportionate
share of healthcare to low-income individuals (Gilman et al., 2014).
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State of Residency: The state in which the physical hospital is located.
Teaching Status: “A hospital is considered a teaching hospital if it has one or
more Accreditation Council for Graduate Medical Education (ACGME) approved
residency program, is a member of the Council of Teaching Hospitals (COTH) or has a
ratio of full-time equivalent interns and residents to beds of .25 or higher” (Healthcare
Cost and Utilization Project, 2008, p. 1).
Assumptions
It is assumed that the 30-day mortality rates used in this study, as collected by
CMS and presented in their hospital compare data, are accurate. Furthermore, it is
assumed that the CMS data, which are derived from only Medicare patients 65 years old
and older (Medicare.gov, n.d.), is an accurate predictor of population health outcomes for
those that fall below the eligibility age. However, the CMS dataset is the only
consistently reported hospital performance information available for comparing US
hospitals.
It is also assumed that the variables are independent of each other. This includes
the method, as described above, in which the Leapfrog grade is calculated from the
hospital safety data. It is important for the statistical analysis that all variables are
independent.
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Limitations
Since the 30-day mortality rates are derived from Medicare patient data, it is a
known limitation of this data that the data is only predictive of patients that are 65 years
or older (Burke et al., 2017).
The Leapfrog grades are derived from both self-reported questionnaires for
participating hospitals and from CMS data for those that do not choose to participate
(Austin et al., 2014).
The analysis was limited to only those organizations that had adequate data
elements. Organizations that did not complete an AHA survey, have a Leapfrog grade,
and at least one dependent variable, were eliminated from the study.
The results of this research only apply to the eight states studied and may not be
conveyable to other U.S. states.
Scope and Delimitations
The scope of this study was limited to the use of comparing the Leapfrog grades
presented on The Leapfrog Group website for each hospital, AHA hospital data, and
Hospital Compare. All secondary data was extracted from publicly available datasets and
analyzed as presented from the various organization without manipulation or
interpretation.
Significance of Study
This study explored the linkage between publically available Leapfrog grades and
patient outcomes. I was able to demonstrate an inconsistent association between
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leapfrog's consumer-accessible Hospital Safety Grades and included 30-day mortality
rates. Therefore, Leapfrog grades were demonstrated to be an unreliable indicator from
which consumers can use to select their healthcare provider on the basis of the analyzed
outcomes. The study was also able to provide information on how the included covariates
were associated with each outcome.
Significance to Practice
Medicine is the art of healing and preventing illness. However, the vast majority
of quality measures are not outcome based. Of the nearly 2,000 quality indicators in the
National Quality Measures Clearinghouse, only 7% (139) are based on patient outcomes
(Porter, Larsson, & Lee, 2016). However, improved patient outcomes, specifically
decreases in mortality rates, are the ultimate end goal of medicine. While the authors
discussed that mortality is rare and may not be a good differentiator among hospitals as a
performance indicator, mortality is an important, and arguably the most important,
outcome measure (Porter, Larsson, & Lee, 2016). The CMS data does exist to allow for
determining significant differences among hospital data, regardless if mortality is a rare
event among all hospitals.
Researching the linkage between Leapfrog grades and CMS available outcome
measures for pneumonia, CHF, and AMI may help determine if correlations exists.
Significance to Social Change
This study provided healthcare consumers with the information needed to
determine the usefulness of available Leapfrog grades for reliably predicting individual
hospital patient outcomes for pneumonia, CHF, and AMI. Furthermore, healthcare
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organizations will be able to use the data to understand how their organizational attributes
(e.g., ownership type) may impact patient outcomes and begin to make enhancements to
increase their levels of care.
Summary and Conclusion
The U.S. healthcare system has been undergoing a change in which consumers
demand safe quality care that provides a positive customer experience. As the U.S.
healthcare system becomes more consumer-focused and driven, it is essential that
consumers have the information necessary to make informed health decisions. These
decisions are not only about which type of treatments and medications they wish to
partake but also which organization in which they wish to receive their care. Leapfrog,
using a proprietary safety grade calculation, is designed to give hospitals an A, B, C, D,
or F grade (to match traditional school grades) to easily convey to consumers the safety
and quality of care provided for a given hospital. While this is admirable, the grades
given to each hospital have the potential to impact the financial health of each
organization. Therefore, it is imperative that the grades be truly indicative of the care
provided and devoid of biases towards a particular subset of hospitals. This study was
designed to ascertain if there is a correlation between Leapfrog scores and 30-day
mortality rates. Furthermore, using the described covariates, the analysis was completed
to determine if organizational descriptors demonstrate a grading bias.
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Section 2: Research Design and Data Collection
Introduction
Section 1 provided the rationality and historical validity for determining if a
correlation is evident between the publicly available Leapfrog grades (independent
variables) and the 30-day mortality rates for CHF, AMI, and pneumonia (dependent
variables) data extracted from the CMS dataset. It was demonstrated that further
stratifying the data across the covariates is also supported by the literature. The use of
the covariates provides a foundation for determining if the Leapfrog grades demonstrate
bias at a level that is statistically significant (p < 0.05). Section 2 provides the research
design, data collection, and analyses of the variables and covariates.
Purpose of the Study
The primary purpose of this study was to determine if Leapfrog hospital grades
are predictive of patient mortality rates for pneumonia, AMI, and CHF using CMS data
from hospitals with other elements from eight states (GA, MD, OH, NC, PA, TN, VA,
and WV) similar to Leapfrog focused studies (Pakyz et al., 2017). While other studies
have looked at the relationship between an organization’s financial performance and
CHF, AMI, and pneumonia mortality rates (Nguyen et al., 2016), this study is unique in
that I examined the information available to consumers on which they base their
healthcare purchasing decisions. Secondarily, a comparison of the linear regressions
derived from each organization’s grade was used to determine if the hospital safetey
grade is predictive of the 30-day mortality data. Since the most significant measure of a

26
healthcare organization’s quality is patient outcomes (e.g., mortality rates), by performing
a retrospective analysis one can compare if the rating organization’s provided healthcare
grades are correlated with hospitals that have better patient outcomes. Additional
stratifications using covariates of hospital-level quality data and descriptors (e.g.,
ownership type) were used to look for relationships, using regression analysis, and biases
that may exist between the grades and other independent variables.
Research Design and Rationale
This study used an inductive relational correlation theoretical approach that is
described by Eisenhardt, Graebner, and Sonenshein (2016) to analyze the data. This
approach is appropriate for determining if the data are predictive in determining if an
association exists between the independent variables (Leapfrog grades and descriptive
characteristics) and the dependent variables (30-day mortality rates). Specifically, the
three dependent variables used for determining correlations will consist of pneumonia,
CHF, and AMI 30-day mortality rates derived from publicly available CMS data.
The study was built upon similar studies that also looked to correlate the
predictability of publicly available health scores/grades and quality indicators. One
similar study sought to determine a relationship between Leapfrog scores and hospitalacquired infections (Pakyz et al., 2017) and provide an approach that was used for this
study.
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Research Questions and Hypotheses
RQ1: Does an organization’s Leapfrog grade demonstrate a statistically
significant correlation with the CMS pneumonia mortality rate data adjusting for each
covariate: licensed beds, ownership type, state of residency, safety net hospital status,
state Medicaid expansion status, and organization’s teaching status?
H11: The available consumer available health organization’s Leapfrog grade is
predictive of patient pneumonia mortality rate data adjusting for each covariate: licensed
beds, ownership type, state of residency, safety net hospital status, state Medicaid
expansion status, and organization’s teaching status.
H01: There is no correlation between Leapfrog grades and patient health mortality
rates based on pneumonia data adjusting for each covariate: licensed beds, ownership
type, state of residency, safety net hospital status, state Medicaid expansion status, and
organization’s teaching status.
RQ2: Does an organization’s Leapfrog grade demonstrate a statistically
significant correlation with CMS congestive heart failure (CHF) patient mortality rate
data adjusting for each covariate: licensed beds, ownership type, state of residency, safety
net hospital status, state Medicaid expansion status, and organization’s teaching status?
H12: The available consumer available health organization’s Leapfrog grade is
predictive of patient chronic heart failure (CHF) mortality rate data adjusting for each
covariate: licensed beds, ownership type, state of residency, safety net hospital status,
state Medicaid expansion status, and organization’s teaching status.

28
H02: There is no correlation between Leapfrog grades and patient mortality rates
based on CHF data adjusting for each covariate: licensed beds, ownership type, state of
residency, safety net hospital status, state Medicaid expansion status, and organization’s
teaching status.
RQ3: Does an organization’s Leapfrog grade demonstrate a statistically
significant correlation with CMS acute myocardial infarctions (AMI) patient mortality
rate data adjusting for each covariate: licensed beds, ownership type, state of residency,
safety net hospital status, state Medicaid expansion status, and organization’s teaching
status?
H13: The available consumer available health organization’s Leapfrog grade is
predictive of patient pneumonia mortality rate data adjusting for each covariate: licensed
beds, ownership type, state of residency, safety net hospital status, state Medicaid
expansion status, and organization’s teaching status.
H03: There is no correlation between Leapfrog grades and patient health mortality
rates based on pneumonia data adjusting for each covariate: licensed beds, ownership
type, state of residency, safety net hospital status, state Medicaid expansion status, and
organization’s teaching status.
Study Population Estimates
Acute care hospitals from eight states (GA, MD, NC, OH, PA, TN, VA, and WV)
that contain required data elements (Table 2) were included. To be included, each
hospital had to have the following minimum data elements: Fall 2018 Leapfrog grade, at
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least one of the three 30-day mortality rates, determined safety-net status, and all AHA
survey elements.
Table 2
Required Data Elements for Study Inclusion
Independent Variables
Data Element
Leapfrog grades

Pneumonia 30-day mortality rate
CHF 30-day mortality rate
AMI 30-day mortality rate

Safety-net status
Ownership Type
Teaching status
Licensed beds (size)
State of residency
Medicaid expansion

Source
2018 Leapfrog Hospital Safety Grades
Dependent Variables
CMS.gov
CMS.gov
CMS.gov
Covariates
CMS.gov (DSH payments)
2017 AHA Survey (ahadataview.com)
2017 AHA Survey (ahadataview.com)
2017 AHA Survey (ahadataview.com)
2017 AHA Survey (ahadataview.com)
Kaiser Family Foundation (KFF.org)

Estimated Sample Size
Table 3 provides the number of acute hospitals that in each state that received
grades by the Leapfrog Group using the Fall 2018 dataset. The total number of available
hospitals was 590. However, the numbers were reduced when additional data elements
were found to be missing from the various datasets.

30

Table 3
Number of Acute Care Hospitals Available for Study (per State)
State
Medicaid Expansion
Number of graded
(as of 12/31/2018)
hospitals
Maryland
Ohio
Pennsylvania
West Virginia
Georgia
North Carolina
Tennessee
Virginia

Yes
Yes
Yes
Yes
No
No
No
No

40
110
132
24
74
79
65
66

Power Analysis
An a priori power analysis was performed using G*Power (Version 3.1.9.2) to
determine if the number of hospitals included in the study would be sufficient to detect a
significant difference at a small effect size (f2 = .02). With an α = 0.05 and at 80%
predictive power, the minimum number of hospitals was 395 (Table 4). The small effect
size was selected due to the expected small difference among facilities and mortality
rates. The 80% predictive power was selected to give a minimum lower level. However,
based on the final sample sizes, all levels were > 85%. There were 468 hospitals
included for AMI mortality rates. Pneumonia and CHF mortality rates each had 522
hospitals analyzed. The study exceeded the a priori minimum power to detect any
differences that exist.
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Table 4
A Priori Predicted Study Size Calculation
Inputs:

Outputs:

Tail(s)
Effect size (f2)
α value
Power
Number of predictors
Sample size
Actual power

2
0.02
0.05
0.80
8
395
0.8006

Secondary Data Types and Sources of Information
The data for each hospital was obtained from the Hospital Compare website at
CMS.gov, the AHA Annual survey data obtained from the AHA website, and the
Leapfrog website. Table 2 details which elements are derived from which source.
Data Collection and Management
All data for this study was obtained from publicly available datasets. No patient or
other protected information was utilized. All data were downloaded directly from the
various sources and kept on both my personal computer and backed-up using cloud
storage.
Study Analytical Strategies
This study used linear regression analysis modeling to determine if statistically
significant correlations exist between the three dependent variables patient outcomes
(pneumonia, CHF, and AMI) and the independent variables while adjusting for each
covariate (licensed beds, ownership type, state of residency, safety-net hospital status,
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state Medicaid expansion status, organization’s safety net designation, and organization’s
teaching status).
All data were analyzed using SPSS (version 25) with the data tables imported
from Microsoft® Excel®. A Means analysis for each independent-dependent
combination was performed using the Compare Means tool. Multiple regressions were
run using the Regression tool.
Initial Significance Modeling: Means Analysis
Each independent was analyzed using the Means test to check for statistical
significance that may exist with each dependent variable before inclusion in the multiple
regression analysis for each dependent variable. The a priori acceptable level of
significance was set at p < .05. Eta Square (η2) value was used to demonstrate the
strength of the association between each independent–dependent variable Means analysis.
For all categorical data elements (Table 5), dummy variables were utilized to allow for
regression analysis. Each independent was analyzed using the Means test to check for
statistical significance that may exist with each dependent variable before including the
independent variables in the multiple regression analysis.
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Table 5
Data Type for Each Study Variable
Data Element

Data Type
Independent Variables

Leapfrog grades

Categorical: A, B, C, D, or F
Dependent Variables

Pneumonia 30-day mortality rate
CHF 30-day mortality rate
AMI 30-day mortality rate

Continuous
Continuous
Continuous
Covariates

Safety-net status

Categorical (dichotomous): Yes or No

Ownership Type

Categorical: for-profit, not-for-profit,
or public

Teaching status

Categorical: Major, Minor, or nonteaching

Licensed beds (size)

Continuous

State of residency

Categorical: GA, MD, NC, OH, PA,
TN, VA, and WV

Medicaid expansion

Categorical (dichotomous): Yes or No
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Multiple Regression Analysis
Three multiple regression analyses were performed, one for each dependent
variable. An a priori p < .05 was used to determine if the model exhibited statistical
significance. The unstandardized β was analyzed to determine the effect size of each
included independent variable. The adjusted R2 was utilized to determine the strength of
the model. VIF score of > 5 was utilized for determining collinearity among the
independent and covariate variables. Any data element that demonstrated
multicollinearity, using VIF or tolerance, was removed from the final regression.
Threats to Validity
Leapfrog grades are calculated by using either hospital supplied data or captured
from Medicare publicly available data. The validity of the data provided to Leapfrog
from each participating organization is not able to be checked to ensure the values are
valid during this study.
Ethical Considerations
I will not have contact with any organization the compiled and supplied the
publicly available datasets (e.g., Leapfrog). There was no primary data collected for this
study. The Walden University institutional review board was consulted and approval
granted before any research was conducted.
Summary
In Section 2, I provided the proposed study design and data collection methods
used for determining a correlation between Leapfrog grades and 30-day mortality rates.
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Additional analysis was performed to determine if any of the indicated covariates
demonstrate any statistically significant correlations. Furthermore, data collecting,
handling, and analysis have also been provided to help ensure all results derived from this
study are valid. Lastly, possible data threats and ethical concerns were addressed.
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Section 3: Presentation of the Results and Findings
Introduction
The primary purpose of this study was to determine if Leapfrog hospital grades
are predictive of patient mortality rates for pneumonia, AMI, and CHF using CMS data
from hospitals with other elements from eight states (GA, MD, OH, NC, PA, TN, VA,
and WV) similar to Leapfrog focused studies (Pakyz et al., 2017). In this section, the
data collection methods, data selection criteria, data analysis methodologies, and a
summary of the statistical results are presented. The final number of hospitals that were
included in the study was 524 with no individual dependent variable having more than
522 hospitals. To be included, each hospital had to have the following minimum data:
Leapfrog grade, at least one of the three 30-day mortality rates, determined safety-net
status, and all AHA survey elements.
Secondary Data Element Collection
Leapfrog Hospital Safety Grades
The Fall 2018 Leapfrog Hospital Safety Grades were the most currently available
when the data was collected from the Leapfrog Group’s website in December 2018. For
each state included in the study (GA, MD, OH, NC, PA, TN, VA, and WV), the selection
was made for search by state and the state was entered. This process allowed for the
propagation of a listing of all hospitals within each state. The list consisted of the
hospital’s name, the hospital’s address, and their corresponding safety grade. Each
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hospital name and corresponding grade was entered into an Excel® spreadsheet. There
were 590 individual hospital entries (see Table 3 for distribution by state).
30-Day Mortality Rates (AMI, CHF, and Pneumonia)
The CMS 30-day mortality rate data was recovered from the CMS.gov website.
The dataset was downloaded as an Excel® file to allow for appropriate sorting. The data
were sorted by state and placed in alphabetical order. All data elements that did not
pertain to the 30-day mortality rate information were eliminated, along with the states not
included in this study. Each Leapfrog hospital had its results manually entered for AMI,
CHF, and pneumonia 30-day mortality rates. Hospitals were matched by facility name
and address. However, when the hospital names did not match, the address of the facility
was used to ensure the facilities were indeed the same. Of the 590 hospitals with
Leapfrog grades, 30-day mortality rates were available for 79.3% (n=468) for AMI,
88.5% (n=522) for CHF, and 88.5% (n=522) for pneumonia.
Table 6 presents the mortality rates for each dependent variable. It is important to
note, and will be used later, the spread of the values among the hospitals for each
dependent variable (AMI=8.6, CHF=10.3, and pneumonia=12.2). The greater the
variability of each mortality rates among the hospitals increases the possibility of
discovering statistical differences among hospitals.
AHA Data Elements (Teaching Status, Number of Beds, and Ownership Type)
Each hospital with a Leapfrog grade had their AHA survey data accessed through
the Health Forum website (ahadataviewer.com) in December 2018 – January 2019.
Health Forum is an affiliate of the AHA and provides access to AHA survey data. An
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attempt was made to find the AHA survey data for each of the 590 Leapfrog hospitals.
An information sheet for each hospital was printed using the “Free Hospital Look-Up”
feature. AHA survey data was found for 90.3% (n=533) of the Leapfrog hospitals. The
57 hospitals without verifiable AHA data were eliminated from the study. All relevant
data elements were manually entered into the data collection spreadsheet.
Safety-Net Status
Safety-net status was derived from the “CMS DSH Payment Percentages” found
on CMS.gov on January 4, 2019. The percentage of DSH payments, as reported by each
hospital, varied between November 2015 and September 2017. Each state’s percentages
were sorted from highest to lowest. The top quartile from each state was designated as a
safety-net hospital regardless of whether the hospitals were included as part of the study.
The sorting of all hospitals allowed for an accurate ranking of the state’s safety-net
hospitals. When there was a tie among hospitals for the final quartile position, all
hospitals with that DSH payment percentage were included as a safety-net hospital. Each
hospital’s safety-net designation manually loaded into the spreadsheet as a dichotomously
coded variable (1 =Yes, 0 =No). Because a disproportionate share of safety-net hospitals
had Leapfrog scores, at least one CMS mortality rate, and AHA survey data (n=533),
43.4% (n=232) of hospital included in the study were designated as safety-net, and 56.6%
(n=302) were not safety-net.
Medicaid Expansion
Each of the study’s eight state’s Medicaid expansion status was through
December 31, 2018. The status of each state was derived from the Kaiser Family
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Foundation’s website (KFF.org). Each hospital’s Medicaid expansion designation
manually loaded into the spreadsheet as a dichotomously coded variable (1 =Yes, 0 =No).
State
Each hospitals state was loaded into the dataset as extracted from the Leapfrog
database and confirmed using both the CMS and AHA datasets. There were no
discrepancies found within the dataset when determining the state in which each hospital
is physically located.
Descriptive Statistics
The descriptive statistics for each dependent variable are listed in Table 6. The
scores for AMI mortality rates: n=468, =13.20, SD=1.15, minimum=10.1, and
maximum=18.7; CHF mortality rates: n=522, =11.57, SD=1.64, minimum=6.7, and
maximum=17.0; pneumonia mortality rates: n=522, =16.07, SD=2.00, minimum=11.3,
and maximum=23.5. Figures 2-4 demonstrate that each dependent variable is normally
distributed around the mean.
Table 6
Descriptive Statistics for Dependent Variables
Variable
n
Min
Max

Mean

SD

AMI 30-Day
Mortality Rate

468

10.1

18.7

13.20

1.15

CHF 30-Day
Mortality Rate

522

6.7

17.0

11.57

1.64

11.3

23.5

16.07

2.00

Pneumonia 30-Day 522
Mortality Rate
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Figure 2: AMI 30-day mortality rate distribution

Figure 3: CHF 30-day mortality rate distribution

Figure 4: Pneumonia 30-day mortality rate distribution
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The descriptive statistics for each independent variable are listed in Table 7. It is
notable that for the Leapfrog grades, that none of the 524 included hospitals received an
“F” for the Fall 2018 grades. The Leapfrog grades were distributed as such: 37.2%
received an “A” (n=195), 24.4% received a “B” (n=128), 33.0% received a “C” (n=173),
and only 5.3% received a “D” (n=28). With the absence of any “F” grades, the
distribution of Leapfrog grades is skewed heavily to the left and does not demonstrate a
normal distribution.
Safety-net hospital status (“Yes” =43.7%, “No” =56.37%) and Medicaid
expansion (“Yes” =51.9%, “No” =48.1%) were nearly equally distributed. The
distribution of teaching status (Major =10.7%, Minor =50.4%, Nonteaching =38.9%) and
ownership type (Not-For-Profit =78.2%, For-Profit =12.4%, Public =9.4%) were not
equally distributed and demonstrated that a strong propensity towards minor teaching
status and not-for-profit status. The distribution of hospitals among the eight states (PA
=21.4%, OH =18.7%, NC =13.7%, GA =13.0%, VA =11.6%, TN=9.7%, MD =7.4%,
WV =4.4%) demonstrate a distribution that very closely resembled each states
population.
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Table 7
Descriptive Statistics for Independent Variables
Variable

n

%

A
B
C
D
F

195
128
173
28
0

37.2%
24.4%
33.0%
5.3%
0.0%

Yes
No

229
295

43.7%
56.3%

Yes

272

51.9%

No

252

48.1%

GA
MD
NC
OH
PA
TN
VA
WV

68
39
72
98
112
51
61
23

13.0%
7.4%
13.7%
18.7%
21.4%
9.7%
11.6%
4.4%

Major
Minor
Non-Teaching

56
264
204

10.7%
50.4%
38.9%

Not-For-Profit
For-Profit
Public

410
65
49

78.2%
12.4%
9.4%

<100
100 – 199
200 – 499
>500

111
151
189
73

21.2%
28.8%
36.1%
13.9%

Leapfrog Grades

Safety-Net Hospital

Medicaid Expansion

State

Teaching Status

Ownership Type

Licensed Bed Groupings
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Study Results
After completing the collection, collating, and description of the data elements for
each hospital, the SPSS Means comparison test was performed with each independent
variable to test significance with each dependent variable. The Means test was done to
ensure that only independent variables that demonstrated significance (p < .05) were
included in the multiple regression analyses.
The multiple regression modeling for each dependent variable was performed
using indicator, or dummy, variables for the noncontinuous independent variables
(Leapfrog grade, state, teaching status, ownership type, and groupings of bed size). For
dichotomous independent variables (safety-net and Medicaid expansion) the data was
entered using binary coding (yes = 1 and no = 0). The reference value for each set of
indicator variables used for the multiple regression analysis was: Leapfrog grade – “A,”
state – Virginia, teaching status – major, ownership type – not-for-profit, and groupings
of bed size – small (< 100 beds).
Research Question #1: Pneumonia Data
RQ1. Does an organization’s Leapfrog grade demonstrate a statistically
significant correlation with the CMS pneumonia mortality rate data adjusting for each
covariate: licensed beds, ownership type, state of residency, safety net hospital status,
state Medicaid expansion status, and organization’s teaching status?
Means comparison testing. Using the ANOVA results from the Means
comparison test, Table 8 depicts that Leapfrog grades (p=.042), Medicaid expansion
(p<.001), state (p<.001), teaching status (p<.001), and ownership type (p<.001) all
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demonstrated statistical significance with 30-day pneumonia mortality rates. However,
safety-net hospital status (p=.964) and number of beds (p=.360) failed to demonstrate
statistical significance and were not included in the multiple regression analyses.
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Table 8
Means Comparison of Independent Variables and Pneumonia 30-Day Mortality Rates
Variable
n
Mean
SD
p
Leapfrog Grades

.042
A
B
C
D

194
127
173
28

15.8
16.3
16.3
15.9

2.0
2.0
2.0
1.4

Safety-Net Hospital

.964
Yes

228

16.1

2.0

No
Medicaid Expansion

294

16.1

2.0

Yes

271

15.5

1.8

No

251

16.6

2.0

<.001

State

<.001
GA
MD
NC
OH
PA
TN
VA
WV

68
39
72
98
111
51
60
23

16.4
16.1
17.3
15.1
15.7
16.7
16.1
15.7

2.1
1.6
1.8
1.8
1.8
2.1
1.9
2.2

Teaching Status

<.001

Major
Minor
Non-Teaching
Ownership Type

55
264
203

15.4
15.9
16.5

1.8
1.9
2.1

Not-For-Profit
For-Profit
Public
Licensed Bed Groupings
<100
100 - 199
200 - 499
>500

409
64
49

15.9
16.8
16.8

2.0
2.0
2.0

111
150
189
72

16.3
16.0
16.1
15.7

1.9
2.1
2.0
2.0

<.001

.360
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Multiple regression analysis. The multiple regression analysis did not
demonstrate multicollinearity, except for Pennsylvania, as all VIF values were < 3.50 and
tolerance values were > .28. Pennsylvania was excluded from the SPSS multiple
regression analysis as the tolerance value (.000) demonstrated multicollinearity. There
was no indication of autocorrelation as the Durbin-Watson score was 1.96. The model
was statistically significant (p < .001) with an adjusted R2 = .132.
Table 9 demonstrates that among the Leapfrog grades, all hospital grades
demonstrated a deterioration (positive unstandardized β indicates an increase in the
percentage of pneumonia deaths) compared those for “A” rated hospitals. Only hospitals
with a “C” grade (β = 0.513, p = .010) was statistically significantly different from the
reference category (“B” = β = 0.358, p = .096; “D” = β = 0.250, p = .519). However, the
actual effect size, as a percentage of the range of pneumonia values (range = 12.2),
demonstrated the effect was small and the actual differences among the grades were
minimal (B = 2.9%, C = 4.2%, and D = 2.0%).
Medicaid expansion did not demonstrate a statistically significant difference (p =
.276) for 30-day pneumonia mortality rates between hospitals that reside in states that
have or have not expanded Medicaid.
Using Virginia as the reference category, only North Carolina (β = 1.156, p =
.001) and Ohio (β = -0.524, p = .044) were significantly different for pneumonia
mortality. North Carolina’s effect size demonstrated a 9.5% increase and Ohio’s effect
size indicated a 4.3% decrease in mortality rates. Pennsylvania was eliminated from the
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multiple regression analysis using SPSS due to the state demonstrating multicollinearity
(tolerance = .000).
Teaching status, using major teaching status as the reference category, nonteaching status (β = 0.734, p = .012) demonstrated 6.0% worse outcomes and minor
teaching status (β = 0.463, p = .098) just failed to exhibit statistical significance.
There was a significant difference demonstrated among not-for-profit (reference
category) and for-profit hospitals (β = 0.678, p = .011), but not for public hospitals (β =
0.159, p = .610). The effect size for the for-profit hospitals revealed a 5.6% increase in
mortality rates.
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Table 9
Multiple Regression Analysis for Pneumonia 30-Day Mortality Rates (N=522)
Variable
Unstandardized
P
VIF
Tolerance
β
Leapfrog Grades
(A = reference category)
B
C
D

.358
.513
.250

.096
.010
.519

1.280
1.328
1.147

.781
.753
.872

Medicaid Expansion

-.331

.276

3.467

.288

.244
.397
1.156
-.524
.312
-.193

.469
.258
.001
.044
.391
.656

1.934
1.283
2.100
1.554
1.751
1.189

.517
.780
.476
.644
.571
.841
.000

.463
.734

.098
.012

2.940
3.002

.340
.333

.678
.159

.011
.610

1.141
1.237

.876
.809

State
(VA = reference category)
GA
MD
NC
OH
TN
WV
PA – excluded variable
Teaching Status
(Major = reference category)
Minor
Non-Teaching
Ownership Type
(Not-For-Profit = reference category)
For-Profit
Public
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Research Question #2: CHF
RQ 2. Does an organization’s Leapfrog grade demonstrate a statistically
significant correlation with CMS congestive heart failure (CHF) patient mortality rate
data adjusting for each covariate: licensed beds, ownership type, state of residency, safety
net hospital status, state Medicaid expansion status, and organization’s teaching status?
Means comparison testing. Using the ANOVA results from the Means
comparison test, Table 10 depicts that Medicaid expansion (p = .003), state (p = .001),
teaching status (p = .003), ownership type (p = .001), and number of beds (p = .033) all
demonstrated statistical significance with 30-day CHF mortality rates. However,
Leapfrog grades (p = .115) and safety-net hospital status (p = .159) failed to demonstrate
statistical significance and were not included in the multiple regression analyses.
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Table 10
Means Comparison of Independent Variables and CHF 30-Day Mortality Rates
Variable
n
Mean
SD
p
Leapfrog Grades

.115
A
B
C
D

194
127
173
28

11.5
11.6
11.8
11.0

1.6
1.6
1.7
1.5

Safety-Net Hospital

.159
Yes

229

11.5

1.6

No
Medicaid Expansion

293

11.7

1.6

Yes

270

11.4

1.7

No

252

11.8

1.5

.003

State

.001
GA
MD
NC
OH
PA
TN
VA
WV

68
39
72
97
111
51
61
23

11.6
10.9
12.1
11.3
11.5
12.2
11.3
11.6

1.6
1.8
1.3
1.8
1.5
1.6
1.5
1.8

Teaching Status

.003

Major
Minor
Non-Teaching
Ownership Type

55
263
204

11.1
11.4
11.8

1.8
1.7
1.5

Not-For-Profit
For-Profit
Public
Licensed Bed Groupings
<100
100 - 199
200 - 499
>500

409
65
48

11.4
11.9
12.3

1.6
1.5
1.7

110
151
189
72

11.9
11.6
11.4
11.3

1.5
1.6
1.7
1.6

.001

.033
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Multiple regression analysis. The multiple regression analysis, as seen in Table
11, did not demonstrate multicollinearity for the tested variables, except for Medicaid
expansion, as all VIF values were < 4.722 and tolerance values were > .211. Medicaid
expansion was removed from the SPSS analysis due to the demonstration of
multicollinearity (tolerance = .000). There was no indication of autocorrelation as the
Durbin-Watson score was 2.085. The model was statistically significant (p < .001) with
the adjusted R2 = .049 revealing the model has a very weak relationship among the
independent variables and CHF mortality rates.
Using Virginia as the reference category, only North Carolina (β = 0.686, p =
.020) and Tennessee (β = 0.761, p = .014) were significantly different for CHF mortality.
Both states demonstrated increased CHF mortality rates (North Carolina = 6.7%,
Tennessee = 7.4%) when compared to Virginia.
When comparing teaching statuses, using major teaching status as the reference
category, minor teaching status (β = 0.222, p = .431) nor non-teaching status (β = 0.358,
p = .251) demonstrated statistical significance for CHF.
There was a significant difference demonstrated among not-for-profit (reference
category) and public hospitals (β = 0.543, p = .044); however, for-profit hospitals (β =
0.253, p = .266) failed to exhibit statistical significance for CHF. The β for public
hospitals suggests a 5.3% increase in CHF mortality than the reference category.
There was no statistically significant difference among hospitals with differences
in the number of licensed beds using small, < 100 beds, as the reference category.
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Medium, 100 – 199, (β = -0.338, p = .099), large, 200 – 499, (β = -0.339, p=.099), and
very large, 500+, (β = -0.523, p = .079).
Table 11
Multiple Regression Analysis for CHF 30-Day Mortality Rates (N=522)
Variable
Unstandardized
P
VIF
β
Medicaid Expansion –excluded variable

Tolerance
.000

State
(VA = reference category)
GA
MD
NC
OH
PA
TN
WV

.302
-2.33
.686
.139
.306
.761
.300

.292
.485
.020
.601
.236
.014
.445

1.901
1.577
2.101
2.177
2.279
1.727
1.326

.526
.634
.476
.459
.439
.579
.754

.222
.358

.431
.251

4.065
4.721

.246
.212

.253
.543

.266
.044

1.152
1.233

.868
.811

-.338
-.339
-.523

.099
.099
.079

1.756
1.991
2.152

.569
.502
.465

Teaching Status
(Major = reference category)
Minor
Non-Teaching
Ownership Type
(Not-For-Profit = indicator variable)
For-Profit
Public
Licensed Bed Groupings
(<100 = reference category)
100 - 199
200 - 499
500+
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Research Question #3: AMI
RQ 3. Does an organization’s Leapfrog grade demonstrate a statistically
significant correlation with CMS acute myocardial infarctions (AMI) patient mortality
rate data adjusting for each covariate: licensed beds, ownership type, state of residency,
safety net hospital status, state Medicaid expansion status, and organization’s teaching
status?
Means comparison testing. Using the ANOVA results from the Means
comparison test, Table 12 depicts that Medicaid expansion (p < .001), state (p < .001),
teaching status (p < .001), and ownership type (p < .001), all demonstrated statistical
significance with 30-day AMI mortality rates. However, Leapfrog grades (p = .345),
safety-net hospital status (p = .395), and number of beds (p = .365) failed to demonstrate
statistical significance and were not included in the multiple regression analyses.
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Table 12
Means Comparison of Independent Variables and AMI 30-Day Mortality Rates
Variable
n
Mean
SD
Leapfrog Grades

p
.345

A
B
C
D

172
114
157
25

13.1
13.2
13.3
13.1

1.2
1.3
1.1
1.1

Safety-Net Hospital

.395
Yes

212

13.3

1.2

No
Medicaid Expansion

256

13.2

1.1

Yes

239

12.9

1.1

No

229

13.5

1.1

<.001

State

<.001
GA

60

13.5

1.2

MD
NC
OH
PA
TN
VA
WV

35
69
81
100
42
58
23

13.0
13.5
12.7
12.9
13.7
13.4
13.3

1.0
1.1
1.1
1.1
1.3
0.9
1.1

Teaching Status

<.001

Major
Minor
Non-Teaching
Ownership Type

55
245
168

13.2
13.0
13.5

1.5
1.1
1.1

Not-For-Profit
For-Profit
Public
Licensed Bed Groupings
<100
100 - 199
200 - 499
>500

371
56
41

13.1
13.7
13.7

1.1
1.1
1.3

70
139
188
71

13.3
13.2
13.2
13.0

0.8
1.1
1.2
1.4

<.001

.360
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Multiple regression analysis. The multiple regression analysis, as seen in Table
13, did not demonstrate multicollinearity, except for Pennsylvania, as all VIF values were
< 3.27 and tolerance values were > .30. Pennsylvania was excluded from the SPSS
multiple regression analysis as the tolerance value (.000) demonstrated multicollinearity.
There was no indication of autocorrelation as the Durbin-Watson score was 1.98. The
model was statistically significant (p < .001) with a weak adjusted R2 = .101.
Medicaid expansion demonstrated that for hospitals in states that did not expand
Medicaid, there was a 4.6% improvement (β = -0.396, p = .031) in AMI mortality rates
when compared with those that did expand Medicaid.
Using Virginia as the reference category, none of the states were significantly
different for AMI mortality rates [GA (β = 0.114, p = .574), MD (β = 0.152, p = .481),
NC (β = -0.004, p = .985), OH (β = -0.122, p = .458), TN (β = 0.182, p = .420), WV (β =
0.320, p = .209)]. Pennsylvania was excluded from the SPSS multiple regression analysis
as the tolerance value (.000) demonstrated multicollinearity.
When comparing teaching statuses, using major teaching status as the reference
category, minor teaching status (β = -0.238, p = .150) nor non-teaching status (β = 0.116,
p = .505) demonstrated statistical significance for AMI.
There was a significant difference demonstrated among not-for-profit (reference
category) and for-profit hospitals (β = 0.392, p = .019), but not for public hospitals (β =
0.384, p = .052). The for-profit β indicated a 4.6% increase in AMI mortality rates.
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Table 13
Multiple Regression Analysis for AMI 30-Day Mortality Rates (N=468)
Variable
Unstandardized
P
VIF
β
Medicaid Expansion

Tolerance

-.396

.031

3.261

.307

.114
.152
-.004
-.122
.182
.320

.574
.481
.985
.458
.420
.209

1.815
1.256
2.093
1.514
1.619
1.184

.551
.796
.478
.661
.618
.845
.000

-.238
.116

.150
.505

2.666
2.737

.375
.365

.392
.384

.019
.052

1.149
1.220

.870
.820

State
(VA = reference category)
GA
MD
NC
OH
TN
WV
PA – excluded variable
Teaching Status
(Major = reference category)
Minor
Non-Teaching
Ownership Type
(Not-For-Profit = reference category)
For-Profit
Public

Summary
Above, the data analysis was presented for both the performed Means
comparisons testing and multiple regression analysis for each dependent variable.
Leapfrog Hospital Safety Grades do not reliably predict patient outcomes for 30-day
patient mortality rates. The regression modeling demonstrated weak relationships for
each dependent variable; however, the pneumonia model was the best at demonstrating
predictable differences among the various independent variables. Additional findings are
that Medicaid expansion correlates with better outcomes for AMI (β = -0.396, p = .031,
decrease of 4.6%), North Carolina has worse outcomes for both pneumonia (β = 1.156, p
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= .001, increase of 9.5%) and CHF (β = 0.686, p = .020, increase of 6.7%), Ohio has
improved pneumonia outcomes (β = -0.524, p = .044, decrease of 4.3%), Tennessee has
worse CHF outcomes (β = 0.761, p = .014, increase of 7.4%), non-teaching hospitals
have poorer pneumonia outcomes (β = 0.734, p = .012, increase of 6.0%), For-Profit
hospitals have worse outcomes for both pneumonia (β = 0.678, p = .011, increase of
5.6%) and AMI (β = 0.392, p = .019, increase of 4.6%), while publicly owned facilities
have worse outcomes for CHF (β = 0.543, p = .044, increase of 5.3%), when adjusting for
other included covariates. Overall, ownership type and selected states (e.g., North
Carolina) was a significant predictor for two of the three dependent variables. While
most of the covariates provided some predictive value for at least one of the included
outcomes, in most cases, the effect (β) was small.
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Section 4: Application to Professional Practice and Implications for Social Change
Introduction
The purpose of this research study was to determine if publicly available Leapfrog
Hospital Safety Grades could be used by healthcare consumers to select hospitals with an
expectation of improved 30-day mortality rates for pneumonia, CHF, and AMI. The data
was also analyzed to determine if specified covariates were correlated with these same
patient outcomes to further assist consumers with their healthcare choices. It is important
that publically available healthcare ratings and information provided to healthcare
consumers are accurate indications of the care provided.
Interpretation of Results
RQ1: Analysis
Leapfrog grades and pneumonia. Leapfrog grades are correlated with 30-day
mortality rates for pneumonia (p = 0.42). Therefore, the H01 is rejected, and H11 is
accepted. The Leapfrog grade does allow consumers to predict 30-day mortality
outcomes for pneumonia, but with a very low level of association (η2 = .016) may lead to
inaccurate predictions despite the acceptable level of statistical significance. However,
only between “A” and “C” grades were differences exhibited among the grades
themselves (p = .010) and pneumonia mortality rates in the multiple regression model.
The model itself exhibited a weak relationship (adjusted R2 = .132) between the included
variables and dependent variable.
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Covariates and pneumonia. When looking at the effect of the various covariates
have on pneumonia mortality rates, there was a significant difference demonstrated for
Medicaid expansion (p < .001), among the states (p < .001), teaching status (p < .001),
and ownership type (p < .001), when analyzed as groups.
When analyzing pneumonia mortality rates for Medicaid expansion, there is
statistically no difference between states that have expanded Medicaid and those that
have not (p = .276) when all significant covariates are analyzed as part of the multiple
regression.
The differences between Virginia (reference value) and North Carolina (β =
1.156, p = .001) was statistically significant and demonstrated that North Carolina has a
significantly higher mortality rate from pneumonia. There was also a statistical
difference demonstrated between Virginia and Ohio (β = -0.524, p = .044). However, in
this case, Ohio has lower mortality rates than Virginia. The remaining did not
demonstrate any statistical difference when compared to Virginia. Therefore, there are
statistically significant differences among states for pneumonia 30-day mortality rates.
Teaching status did demonstrate a statistical difference between major teaching
(reference category) and hospitals that are non-teaching (β = 0.734, p = .012). These
results demonstrate that non-teaching hospitals worse 30-day mortality rates for patients
with pneumonia than those patients treated at major teaching hospitals. There was no
difference, at the a priori p < .05 level, between major teaching and minor teaching (β =
0.463, p = .098). However, the differences are such that major teaching hospitals may do
a better job of treating pneumonia, thus reducing the mortality rates, at least when
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compared to non-teaching hospitals. It is important to note that 84% of major teaching
hospitals in this study are not-for-profit organizations. Therefore, the linkage between
major teaching status and ownership type might explain a lot of the effect being
demonstrated in both categories.
Ownership type demonstrated a significant difference among not-for-profit
(reference category) and for-profit hospitals (β = 0.678, p = .011), but not for public
hospitals (β = 0.159, p = .610). The data demonstrated that not-for-profit hospitals do
have a 5.6% decrease in pneumonia mortality than for-profit hospitals.
RQ2: Analysis
Leapfrog grades and CHF. Leapfrog grades were found not to be correlated
with 30-day mortality rates for CHF (p = .115). Leapfrog grades had a very weak
association (η2 = .011) with CHF mortality rates. Therefore, the H02 cannot be rejected,
and must be is accepted. The Leapfrog grades are not a reliable tool for consumers to
predict 30-day mortality outcomes for CHF. The lack of correlation between a hospital’s
Leapfrog grade and patient CHF outcomes is a significant finding and will be discussed
further.
Covariates and CHF. When looking at the effect of the various covariates have
on CHF mortality rates, there was significant difference demonstrated for Medicaid
expansion (p = .003), state (p = .001), teaching status (p = .003), ownership type (p =
.001), and number of beds (p = .033). The only covariate that failed to demonstrate
statistical significance for 30-day CHF mortality rates was safety-net hospital status (p =
.159). It is important to note that the model demonstrates a weak relationship (adjusted
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R2 = .050) as almost none of the variance in the dependent variable is explained by the
independent variables.
Medicaid expansion, while being correlated with CHF outcomes, was unable to
be used as part of the multiple regression analysis due to multiple collinearity (tolerance
= .000), and was excluded from the analysis by SPSS. However, it is still notable that
Medicaid expansion is correlated with CHF outcomes, and can be used a predictor.
When compared individually to Virginia, North Carolina (β = 0.686, p = .020)
and Tennessee (β = 0.761, p = .014) both demonstrated worse 30-day outcomes for
patients with CHF. While none of the other states demonstrated a statistically
significance when compared to Virginia, the analysis demonstrates that there are
significant differences among states and CHF outcomes.
Teaching status failed to demonstrate any difference among hospitals for patient
outcomes for CHF using major teaching status as the reference category. The individual
comparison between major teaching and both minor teaching (β = 0.222, p = .431) and
non-teaching (β = .358, p = .251) hospitals did not have either value even approach
significance.
Ownership type, using not-for-profit as the reference category, demonstrated a
significant difference with public hospitals (β = 0.543, p = .044); however, for-profit
hospitals (β = .253, p = .266) did not demonstrate any such difference. Therefore, notfor-profit hospitals do demonstrate significantly better outcomes for CHF than public
hospitals.
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All hospitals sizes [Medium, 100 – 199, (β = -0.338, p = .099), large, 200 – 499,
(β = -0.339, p = .099), and very large, 500+, (β = -0.523, p = .079)] demonstrated
improved CHF mortality rates when compared to small hospitals at the p < 0.1 level.
However, the a priori significance level for this study was established at p < .05;
therefore, none of the numbers are considered to be statistically significant for this study.
RQ3: Analysis
Leapfrog grades and AMI. Leapfrog grades were found not to be correlated
with 30-day mortality rates for AMI (p = .345). Leapfrog grades had an extremely weak
association (η2 = .007) with AMI mortality rates. Therefore, the H03 cannot be rejected,
and must be is accepted. The Leapfrog grades are not a reliable tool for consumers to
predict 30-day mortality outcomes for AMI. The lack of correlation between a hospital’s
Leapfrog grade and patient AMI outcomes is a significant finding and will be discussed
further.
Covariates and AMI. When analyzing the effect of the various covariates, using
Means comparison, on AMI mortality rates, there was significant difference
demonstrated for Medicaid expansion (p < .001), state (p < .001), teaching status (p <
.001), and ownership type (p < .001). Safety-net status (p = .395) and number of beds (p
= .360) failed to demonstrate statistical significance for 30-day AMI mortality rates. In
addition, the model demonstrated a weak relationship (adjusted R2 = .101) as most of the
variance in the dependent variable is not explained by the independent variables.
Medicaid expansion results demonstrated that patients in states without Medicaid
expansion (β = 0.396, p = .031) had worse 30-day mortality rates for AMI than those
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states that did expand Medicaid. The reasons for improved patient outcomes for patients
in states with Medicaid expansion are outside the scope of this study but may warrant
further study.
State comparisons with Virginia demonstrated that the various states did not
demonstrate any statistical differences for AMI mortality rates. While there was a
correlation for the states, when taken as a whole, and AMI outcomes, there was no
difference when the states were compared to Virginia. However, this does not mean, if a
different state was used as a reference category, that some differences in AMI results
would not be demonstrated.
When comparing teaching statuses, using major teaching status as the reference
category, minor teaching status (β = -0.238, p = .150) nor nonteaching status (β = 0.116,
p = .505) demonstrated statistical significance for AMI. Therefore, while teaching status
can be correlated with AMI mortality rates, when the results are compared to major
teaching status, there are no statistical differences observed. There might be differences
seen if a different reference category was utilized.
There was a significant difference demonstrated among not-for-profit (reference
category) and for-profit hospitals (β = 0.392, p = .019). However, public hospitals (β =
0.384, p = .052) just failed to exhibit statistical significance when compared to the
study’s a prior p-value of < .05. In each case, both for-profit and public had worse
patient outcomes for AMI mortality rates. Future studies that include all 50 states might
be able to further elucidate the strength of the relationship between ownership type and
AMI mortality rates.
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Limitations of the Study
Since the 30-day mortality rates are derived from Medicare patient data, it is a
known limitation of this data that the data is only predictive of patients that are 65 years
or older (Burke, Frakt, Khullar, Orav, & Jha, 2017). In addition, Leapfrog grades are
derived from both self-reported questionnaires for participating hospitals and from CMS
data for those that do not choose to participate (Austin et al., 2014). The analysis was
limited to only those organizations that had adequate data elements. Organizations that
did not complete an AHA survey, have a Leapfrog grade, and at least one dependent
variable, were eliminated from the study. Finally, the results of this research only apply
to the eight states studied and may not be conveyable to other US states.

Recommendation
The study demonstrated, within the stated limitations, that Leapfrog Hospital
Safety Grades are not particularly useful for consumers to utilize if selecting a care
provider expecting different mortality rates for the hospitals included. Therefore,
Leapfrog Hospital Safety Grades should not be used to differentiate hospitals for patient
outcomes. The data did demonstrate that some hospital characteristics could be utilized as
predictors of potential patient outcomes, especially with pneumonia 30-day mortality
rates, within the eight US states that were included. It is recommended that this study is
expanded to include all 50 US States to ensure a regional bias is not being demonstrated.
Furthermore, the expansion to all 50 States would help account for variabilities that may
exist among regions and populations.
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Implications for Professional Practice and Social Change
The study was able to demonstrate that healthcare consumers cannot rely upon
Leapfrog grades to predict differences among hospitals for 30-day mortality rates for
pneumonia, CHF, and AMI. The demonstration of the lack of linkage should cause
healthcare consumers to look for other possible indicators for predicting outcomes. The
study also provided a connection between various hospital descriptors (selected states,
ownership type, and teaching status) that demonstrated that efforts to reduce 30-day
mortality rates, especially for pneumonia, can be targeted for improvement.

Professional Practice
Healthcare continues to become more customer focused, and the amount of
available quality information is also expanding to provide consumers with the
information to select their healthcare providers (Scanlon, Shi, Bhandari, & Christianson,
2015). It is essential that the provider quality information is meaningful and indicative of
the care provided. Studies, such as this one, are essential to analyze consumer available
scores and grades to determine if correlations exist between the various ratings and
patient care. Healthcare providers, like healthcare consumers, must be aware of how
their care is represented within each rating system. Knowing how each rating system
represents care allows healthcare providers and organizations to know which areas to
focus their process improvement activities while benchmarking themselves against
similar organizations.
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Positive Social Change
The one facet of healthcare that can never be lost among the current wave of
patient satisfaction initiatives is the importance of understanding that patient outcomes,
specifically reduced mortality risks, are still the most critical aspect of care to healthcare
consumers (Mühlbacher & Bethge, 2015). Therefore, determining if there is an
alignment between publicly available healthcare provider ratings and patient outcome
data, allows healthcare consumers to make more informed decisions where to receive
their care. Studies, like this one, continue to demonstrate the strengths and weaknesses of
the various rating systems and ensure they align with consumer expectations. While this
study helped elucidate that Leapfrog grades are not reliable predictors of patient
outcomes, it also demonstrated that efforts to reduce 30-day mortality rates, especially for
pneumonia, can be targeted by selected states, ownership type, and teaching status.
Conclusion
Leapfrog Hospital Safety Grades demonstrated a statistically significant
correlation for pneumonia 30-day mortality rates. However, Leapfrog grades are poorly
correlated with patient 30-day mortality outcomes for CHF and AMI. The study also
demonstrated, except for ownership type, the independent variables could not be used as
a reliable predictor of patient outcomes across all three dependent variables. However,
except for safety-net status, all the covariates did provide some predictive value of for at
least one of the analyzed outcomes. Organizational ownership type did provide
predictive value for all three depended variables. However, in most cases, the effect (β)
was small.
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The lack of a consistent correlation between Leapfrog grades and patient
outcomes is a significant finding. Since mortality risk is still the most critical factor for
patients (Mühlbacher & Bethge, 2015), demonstrating how publicly available grades
align, or fail to align, with outcomes is of importance to healthcare consumers. This
study demonstrates that there is a gap, at least between Leapfrog grades and the CHF and
AMI outcomes, which need to be addressed to ensure that rating systems are consistently
ranking per what is vital to consumers.

68
References
Agency for Healthcare Research and Quality (2005). AHRQ releases standardized
hospital bed definitions. Retrieved from
https://archive.ahrq.gov/research/havbed/definitions.htm
Anderson, M. E., Glasheen, J. J., Anoff, D., Pierce, R., Lane, M., & Jones, C. D. (2016).
Impact of state medicaid expansion status on length of stay and in‐hospital
mortality for general medicine patients at U.S. academic medical centers. Journal
of Hospital Medicine, 11(12), 847-852. doi:10.1002/jhm.2649
Andersen, R. M. (1995). Revisiting the behavioral model and access to medical care:
does it matter?. Journal of Health and Social Behavior, 36(1), 1-10. Retrieved
from http://www.jstor.org/stable/2137284
Austin, J. M., D’Andrea, G., Birkmeyer, J. D., Leape, L. L., Milstein, A., Pronovost, P.
J., ... & Wachter, R. M. (2014). Safety in numbers: the development of Leapfrog’s
composite patient safety score for US hospitals. Journal of Patient Safety, 10(1),
64-71. doi:10.1097/PTS.0b013e3182952644
Austin, J. M., Jha, A. K., Romano, P. S., Singer, S. J., Vogus, T. J., Wachter, R. M., &
Pronovost, P. J. (2015). National hospital rating systems share few common
scores and may generate confusion instead of clarity. Health Affairs, 34(3), 423430. doi:10.1377/hlthaff.2014.0201
Bai, G., & Anderson, G. F. (2016). A more detailed understanding of factors associated
with hospital profitability. Health Affairs, 35(5), 889-897.
doi:10.1377/hlthaff.2015.1193

69
Bhatt, C. B., & Beck-Sagué, C. M. (2018). Medicaid Expansion and Infant Mortality in
the United States. American Journal of Public Health, 108(4), 565–567.
doi:10.2105/AJPH.2017.304218
Burke, L. G., Frakt, A. B., Khullar, D., Orav, E. J., & Jha, A. K. (2017). Association
between teaching status and mortality in US hospitals. Journal of the American
Medical Association, 317(20), 2105-2113. doi:10.1001/jama.2017.5702
Burstin, H., Leatherman, S., & Goldmann, D. (2016). The evolution of healthcare quality
measurementin the United States. Journal of Internal Medicine, 279(2), 154-159.
doi:10.1111/joim.12471
Cid Pedraza, C., Herrera, C. A., Prieto Toledo, L., & Oyarzún, F. (2015). Mortality
outcomes in hospitals with public, private not-for-profit and private for-profit
ownership in Chile 2001–2010. Health policy and planning, 30(suppl_1), i75-i81.
doi:10.1093/heapol/czu143
CMS.gov. (2006). Glossary. Retrieved from
https://www.cms.gov/apps/glossary/default.asp?Letter=C&Language=English
CMS.gov. (2016). Hospital Compare. Retrieved from
https://www.cms.gov/medicare/quality-initiatives-patient-assessmentinstruments/hospitalqualityinits/hospitalcompare.html

70
Dy, S. M., Chan, K. S., Chang, H. Y., Zhang, A., Zhu, J., & Mylod, D. (2016). Patient
perspectives of care and process and outcome quality measures for heart failure
admissions in US hospitals: how are they related in the era of public reporting?
International Journal for Quality in Health Care, 28(4), 522-528.
doi:10.1093/intqhc/mzw063
Eisenhardt, K. M., Graebner, M. E., & Sonenshein, S. (2016). Grand Challenges and
Inductive Methods: Rigor without Rigor Mortis. Academy of Management
Journal, 59(4), 1113-1123. doi:10.5465/amj.2016.4004
Evans, J. R., & Mai, F. (2014). Insights from the Baldrige Award item-level blinded
applicant scoring data. Quality Management Journal, 21(2), 45-64.
doi:10.1080/10686967.2014.11918384
Figueroa, J. F., Wang, D. E., & Jha, A. K. (2016). Characteristics of hospitals receiving
the largest penalties by U.S. pay-for-performance programs. British Medical
Journal of Quality and Safety, 25, 898-900. doi:10.1136/bmjqs-2015-005040
Gilman, M., Adams, E. K., Hockenberry, J. M., Wilson, I. B., Milstein, A. S., & Becker,
E. R. (2014). California safety-net hospitals likely to be penalized by ACA value,
readmission, and meaningful-use programs. Health Affairs, 33(8), 1314-1322.
doi:10.1377/hlthaff.2014.0138
Gilman, M., Adams, E. K., Hockenberry, J. M., Milstein, A. S., Wilson, I. B., & Becker,
E. R. (2015). Safety-net hospitals more likely than other hospitals to fare poorly
under Medicare’s value-based purchasing. Health Affairs, 34(3), 398-405.
doi:10.1377/hlthaff.2014.1059

71
Healthcare.gov. (n.d.). Affordable Care Act (ACA). Retrieved from
https://www.healthcare.gov/glossary/affordable-care-act/
Healthcare Cost and Utilization Project (HCUP). (2008). HCUP NIS Description of Data
Elements. Retrieved from https://www.hcupus.ahrq.gov/db/vars/
hosp_teach/nisnote.jsp
Herrin, J., St. Andre, J., Kenward, K., Joshi, M. S., Audet, A. M. J., & Hines, S. C.
(2015). Community factors and hospital readmission rates. Health Services
Research, 50(1), 20-39. doi:10.1111/1475-6773.12177
Hicks, C. W., Canner, J. K., Arhuidese, I., Obeid, T., Black, J. H., & Malas, M. B.
(2016). Comprehensive assessment of factors associated with in-hospital
mortality after elective abdominal aortic aneurysm repair. Journal of American
Medical Association - Surgery, 151(9), 838-845. doi:10.1001/jamasurg.2016.0782
Hu, J., Jordan, J., Rubinfeld, I., Schreiber, M., Waterman, B., & Nerenz, D. (2017).
Correlations among hospital quality measures: What “Hospital Compare” data tell
us. American Journal of Medical Quality, 32(6), 605–610.
doi:10.1177/1062860616684012
Kaiser Family Foundation. (2018). Status of State Action on the Medicaid Expansion
Decision. Retrieved from https://www.kff.org/health-reform/state-indicator/stateactivity-around-expanding-medicaid-under-the-affordable-careact/?currentTimeframe=0&sortModel=%7B%22colId%22:%22Location%22,%22
sort%22:%22asc%22%7D

72
Manary, M., Staelin, R., Boulding, W., & Glickman, S. W. (2015). Payer mix & financial
health drive hospital quality: Implications for value-based reimbursement
policies. Behavioral Science & Policy, 1(1), 77-84. doi:10.1353/bsp.2015.0007
Medicare.gov. (n.d.). Hospital Compare: 30-day death (mortality) rates. Retrieved
from https://www.medicare.gov/hospitalcompare/Data/Death-rates.html
Mendez, C. M., Harrington, D. W., Christenson, P., & Spellberg, B. (2014). Impact of
Hospital Variables on Case Mix Index as a Marker of Disease Severity.
Population Health Management, 17(1), 28-34. doi:10.1089/pop.2013.0002
Mühlbacher, A. C., & Bethge, S. (2015). Reduce mortality risk above all else: a discretechoice experiment in acute coronary syndrome patients. Pharmacoeconomics,
33(1), 71-81. doi:10.1007/s40273-014-0223-1
Nguyen, O. K., Halm, E. A., & Makam, A. N. (2016). Relationship between hospital
financial performance and publicly reported outcomes. Journal of Hospital
Medicine, 11(7), 481-488. doi:10.1002/jhm.2570
Pakyz, A. L., Wang, H., Ozcan, Y. A., Edmond, M. B., & Vogus, T. J. (2017). Leapfrog
Hospital Safety Score, Magnet Designation, and Healthcare-Associated Infections
in United States Hospitals. Journal of Patient Safety.
doi:10.1097/PTS.0000000000000378
Ponikowski, P., Voors, A. A., Anker, S. D., Bueno, H., Cleland, J. G. F., Coats, A. J. S.,
… van der Meer, P. (2016). 2016 ESC Guidelines for the diagnosis and treatment
of acute and chronic heart failure. European Journal of Heart Failure, 18, 891975. doi: 10.1002/ejhf.592

73
Porter, M. E., Larsson, S., & Lee, T. H. (2016). Standardizing Patient Outcomes
Measurement. New England Journal of Medicine, 374(6), 504-506.
doi:10.1056/NEJMp1511701
Prina, E., Ranzani, O. T., & Torres, A. (2015). Community-acquired pneumonia. The
Lancet, 386(9998), 1097-1108. doi:10.1016/S0140-6736(15)60733-4
Rivard, P. E., Christiansen, C. L., Zhao, S., Elixhauser, A. & Rosen, A. K. (2008). Is
there an association between patient safety indicators and hospital teaching
status?. In Henriksen K., Battles J. B., Keyes M.A., & Grady M. L. (Ed.), Source
Advances in Patient Safety: New Directions and Alternative Approaches (Vol. 2:
Culture and Redesign) (1-10). Rockville (MD): Agency for Healthcare Research
and Quality (US). Retrieved from
https://www.ncbi.nlm.nih.gov/books/NBK43711/?report=reader
Roth, G. A., Dwyer-Lindgren, L., Bertozzi-Villa, A., Stubbs, R. W., Morozoff, C.,
Naghavi, M., ... & Murray, C. J. (2017). Trends and patterns of geographic
variation in cardiovascular mortality among US counties, 1980-2014. Journal of
the American Medical Association, 317(19), 1976-1992.
doi:10.1001/jama.2017.4150
Rothberg, M. B., Morsi, E., Benjamin, E. M., Pekow, P. S., & Lindenauer, P. K. (2008).
Choosing the best hospital: The limitations of public quality reporting. Health
Affairs, 27(6), 1680-1687. doi:10.1377/hlthaff.27.6.1680

74
Ryan, A. M., Nallamothu, B. K., & Dimick, J. B. (2012). Medicare’s public reporting
initiative on hospital quality had modest or no impact on mortality from three key
conditions. Health Affairs, 31(3), 585-592. doi:10.1377/hlthaff.2011.0719
Sandmeyer, B., & Fraser, I. (2016). New evidence on what works in effective public
reporting. Health Services Research, 51(3), 1159-1166.
doi:10.1111/1475-6773.12502
Scanlon, D. P., Shi, Y., Bhandari, N., Christianson, J. B. (2015). Are healthcare quality
“report cards” reaching consumers? Awareness in the chronically ill population.
American Journal of American Journal of Managed Care, 21(3), 236-244.
Retrieved from https://www.ajmc.com/journals/issue/2015/2015-vol21-n3/arehealthcare-quality-report-cards-reaching-consumers-awareness-in-thechronically-ill-population?p=1
Schulingkamp, R. C., & Latham, J. R. (2015). Healthcare performance excellence: A
comparison of baldrige award recipients and competitors. The Quality
Management Journal, 22(3), 6-22. Retrieved from
https://secure.asq.org/perl/msg.pl?prvurl=http://asq.org/qualitymanagement/2015/07/baldrige-program/healthcare-performance-excellence-acomparison-of-baldrige-award-recipients-and-competitors.pdf
Shahian, D. M., Wolf, R. E., Iezzoni, L. I., Kirle, L., & Normand, S. L. T. (2010).
Variability in the measurement of hospital-wide mortality rates. New England
Journal of Medicine, 363(26), 2530-2539. doi:10.1056/NEJMsa1006396

75
Sheetz, K. H., Dimick, J. B., & Ghaferi, A. A. (2016). Impact of hospital characteristics
on failure to rescue following major surgery. Annals of surgery, 263(4), 692-697.
doi:10.1097/SLA.0000000000001414
Singh, G. K., Siahpush, M., Azuine, R. E., & Williams, S. D. (2015). Widening
socioeconomic and racial disparities in cardiovascular disease mortality in the
United States, 1969-2013. International Journal of MCH and AIDS, 3(2), 106–
118. Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5005986/
Smith, S. N., Reichert, H., Ameling, J., & Meddings, J. (2017). Dissecting Leapfrog:
How well do Leapfrog Safe Practices Scores correlate with Hospital Compare
ratings and penalties, and how much do they matter?. Medical care, 55(6), 606 –
614. doi:10.1097/MLR.0000000000000716
Tefera, L., Lehrman, W. G., & Conway, P. (2016). Measurement of the patient
experience: clarifying facts, myths, and approaches. Journal of American Medical
Association, 315(20), 2167-2168. doi:10.1001/jama.2016.1652
The Leapfrog Group. (n.d.). About the Leapfrog Group. Retrieved from
http://www.Leapfroggroup.org/
The Leapfrog Group. (2018). Leapfrog hospital safety grade: Scoring methodology.
Retrieved from
https://www.hospitalsafetygrade.org/media/file/HospitalSafetyGrade_ScoringMet
hodology_Fall2018_Final2.pdf

76
Thygesen, K., Alpert, J. S., Jaffe, A. S., Simoons, M. L., Chaitman, B. R., & White, H. D.
(2012). Third universal definition of myocardial infarction. Journal of the
American College of Cardiology, 60(16), 1581-98.
doi:10.1016/j.jacc.2012.08.001
Zhao, M., Haley, D. R., Spaulding, A., & Balogh, H. A. (2015). Value-based purchasing,
efficiency, and hospital performance. The Health Care Manager, 34(1), 4-13.
doi:10.1097/HCM.0000000000000048

